Similarly, through analysis of 326 patients with GBM, we observed that patients aged >50 years, with non-seizures symptoms, with IDH wild-type status, and with tumors in mixed areas tended to have inferior OS than that of patients in other subgroups, which was consistent with the findings of previous studies. This evidence concerns the gene IDH1 and glioblastoma.